NCT00981318View on ClinicalTrials.gov

Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

PHASE4TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
HIV InfectionsAcquired Immunodeficiency Syndrome
Interventions
DRUG

lopinavir/ritonavir plus maraviroc

lopinavir/ritonavir 400/100 mg bid plus maraviroc 150 mg bid

Trial Locations (1)

34695

Barry M. Rodwick, M. D., Safety Harbor

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Rodwick, Barry M., M.D.

INDIV